Chinese authorities have acknowledged that supplies of Paxlovid are still insufficient to meet demand, even as Pfizer CEO Albert Bourla said last week that thousands of courses of the treatment were shipped to the country last year and in the past couple of weeks millions more were shipped.
Posts
The cooperative agreement involves the distribution of the COVID-19 antibody drug Evusheld.
The company said today it would take legal action against some pharmaceutical companies after noticing that some manufacturers were supplying COVID-19 drugs to some provinces and cities saying the medicines were authorized by Merck.
Pfizer Inc. is not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said on Monday.
China is in talks with Pfizer Inc. to secure a license that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm’s COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.
China gave a presentation on its COVID-19 situation in an online meeting with the World Health Organization and its member states, China’s national health commission and diplomats said on Thursday, as it seeks to fend off criticism about its recent reporting on the outbreak.
No new coronavirus variant has been found in China, data released by the World Health Organization showed on Wednesday, easing some concerns about an outbreak that has spread rapidly there since Beijing abruptly reversed its “zero COVID” policy.
Leading scientists advising the World Health Organization said they wanted a “more realistic picture” about the COVID-19 situation from China’s top experts at a key meeting on Tuesday as worries grow about the rapid spread of the virus.
The European Union has offered free COVID-19 vaccines to China, the EU executive said on Tuesday, as infections there surged following Beijing’s relaxation of its “zero-COVID” policies.
State media in China played down the severity of a surge of COVID-19 infections ahead of an expected briefing on Tuesday by its scientists to the World Health Organization, which is hoping for a “detailed discussion” on the evolution of the virus.
